FDA issued a warning letter to a compounder citing violations based on making copies of FDA-approved GLP-1 drugs. The warning letter to Empower Pharmacy also cites sterility concerns because their drugs were made in a facility where FDA observed insanitary conditions. FDA is committed to protecting patients from poor quality compounded GLP-1 drugs and will continue taking action when companies fail to follow federal law.
published
FDA issued a warning letter to a compounder citing violations based on making copies of FDA-approved GLP-1 drugs. The warning letter to Empower Pharmacy also cites sterility concerns because their drugs were made in a facility where FDA observed insanitary con
Latest documented BWB result
$APP market result
Exit $APP Sold Puts for a nice profit and then sold more Puts - this time the $325's for $3.97
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.